Catalent, Inc.
NYSE: CTLT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Alessandro Maselli
- Employees
- 17,000
- Headquarters
- Somerset, United States
- IPO year
- 2014
- Market cap
- $11.5B
- Website
- https://www.catalent.com
Loading CTLT…
Loading profile data…Frequently asked questions about CTLT
What does Catalent, Inc. (CTLT) do?
Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into f...
Where does CTLT trade?
Catalent, Inc. (CTLT) trades on the New York Stock Exchange.
What sector is CTLT in?
Catalent, Inc. (CTLT) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Catalent, Inc.?
Alessandro Maselli is the chief executive officer of Catalent, Inc. (CTLT).
Where is Catalent, Inc. headquartered?
Catalent, Inc. is headquartered in United States.
Does CTLT pay a dividend?
Catalent, Inc. (CTLT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CTLT go public?
Catalent, Inc. (CTLT) completed its initial public offering in 2014.